3D-Printed tumors could predict best liver cancer drugs
NCT ID NCT07437859
First seen Mar 04, 2026 · Last updated May 14, 2026 · Updated 14 times
Summary
This study explores whether 3D bioprinting can create personalized liver cancer models from a patient's own tumor tissue. These models are then tested with different drugs to see which ones work best, aiming to improve treatment choices. The study involves 60 adults with primary liver cancer and focuses on matching lab results to real patient responses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Medical College hospital
Beijing, Beijing Municipality, 100730, China
Conditions
Explore the condition pages connected to this study.